Trial · NCT02442791
GLP-1 Analogs for Neuroprotection After Cardiac Arrest
NCT02442791, Not applicable, Completed, Jesper Kjaergaard
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. GLP-1 Analogs for Neuroprotection After Cardiac Arrest. Trials, record NCT02442791. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02442791
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- NCT number
- NCT02442791
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 120 participants, actual
- Lead sponsor
- Jesper Kjaergaard
- Conditions
- Cardiac Arrest, Coma
- Interventions
- Byetta (Lilly, Exenatide), 20% Human Albumin
- First posted
- 2015-05-13
- Last updated
- 2017-09-28
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility: Over 90% initiation of study drug infusion | 4 hours from return of spontaneous circulation | |
| Primary | Efficacy assessed by Area under the Neuron-specific Enolase curve | 72 hours from admission | |
| Secondary | Neurological prognostication | Day 5 | Blinded neurological evaluation by neurologist on "VAS-scale" |
| Secondary | Area under Neuron-specific Enolase curves (NSE) | 48 hours | Daily measurements of NSE values |
| Secondary | All cause mortality | 180 days | Vital status by end of study by registry based follow-up |
| Secondary | Cerebral status | 30 days, 90 days and 180 days | Telephone based assessment of Cerebral Performance Category and modified Rankin Scale. |
| Secondary | Safety: Cumulated incidence of serious adverse events related to study drug: death, need for mechanical hemodynamic support, hypoglycaemia < 3.0 mmol/l, pancreatitis (S-amylase > 3 UNL), need for renal replacement therapy in the first 3 days. | 180 days | |
| Secondary | Area under S100b curve | 48 hours | Daily measurements of S100b |
| Other | Left Ventricular Ejection Fraction (LVEF) | Day 5 or later | LVEF on last in-hospital echocardiogram. |
| Other | EEG findings | Day 3 to 5 | Presence of EEG findings associated with poor prognosis. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02442791
GET https://conductscience.org/api/trials/v1/NCT02442791/registered